Email updates

Keep up to date with the latest news and content from BMC Biochemistry and BioMed Central.

This article is part of the supplement: Ubiquitin-Proteasome System in Disease Part 1

Open Access Highly Accessed Review

Role of the ubiquitin proteasome system in Parkinson's disease

Kah-Leong Lim123* and Jeanne MM Tan1

Author Affiliations

1 Neurodegeneration Research Laboratory, National Neuroscience Institute, Singapore

2 Parkinson's Disease and Movement Disorders Center, National Neuroscience Institute, Singapore

3 Department of Biological Sciences, National University of Singapore, Singapore

For all author emails, please log on.

BMC Biochemistry 2007, 8(Suppl 1):S13  doi:10.1186/1471-2091-8-S1-S13

Published: 22 November 2007


Parkinson's disease (PD) is the most common neurodegenerative movement disorder. Although a subject of intense research, the etiology of PD remains poorly understood. Recently, several lines of evidence have implicated an intimate link between aberrations in the ubiquitin proteasome system (UPS) and PD pathogenesis. Derangements of the UPS, which normally functions as a type of protein degradation machinery, lead to alterations in protein homeostasis that could conceivably promote the toxic accumulation of proteins detrimental to neuronal survival. Not surprisingly, various cellular and animal models of PD that are based on direct disruption of UPS function reproduce the most prominent features of PD. Although persuasive, new developments in the past few years have in fact raised serious questions about the link between the UPS and PD. Here I review current thoughts and controversies about their relationship and discuss whether strategies aimed at mitigating UPS dysfunction could represent rational ways to intervene in the disease.

Publication history: Republished from Current BioData's Targeted Proteins database (TPdb; webcite).